Caihui Ao

Beijing Medical University, Peping, Beijing, China

Are you Caihui Ao?

Claim your profile

Publications (2)4.21 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: TZDs (thiazolidinediones) are prescribed as anti-Type II diabetes drugs, but little is known regarding whether TZDs regulate the expression of sPLA2 (secretory phospholipase A2) in macrophages. We have investigated the effects of pioglitazone on LPS (lipopolysaccharide)-induced production of TNF-alpha (tumour necrosis factor alpha), sPLA2-V and -X (groups V and X sPLA2) in RAW 264.7 macrophages. TNF-alpha, sPLA2-V and -X mRNA and protein expression were determined by RT-PCR (reverse transcriptase-PCR) and Western blot analysis, respectively. The activity of NF-kappaB (nuclear factor kappaB) was determined by Western blot and confocal microscopy. LPS induced TNF-alpha, sPLA2-V and sPLA2-X mRNA and protein expression. Pretreatment with 10 mumol/l pioglitazone significantly suppressed LPS-induced TNF-alpha, sPLA2-V and sPLA2-X mRNA and protein expression. LPS induced NF-kappaB expression and translocation in the nucleus, but the inductive effects were inhibited by pioglitazone. Our findings indicate that pioglitazone inhibits production of inflammatory factors induced by LPS in murine macrophage cells by inactivating NF-kappaB. Pioglitazone appears to play an anti-inflammatory role in the atherosclerotic process.
    No preview · Article · Sep 2009 · Cell Biology International
  • [Show abstract] [Hide abstract]
    ABSTRACT: To examine the plasma levels of secretory type IIA phospholipase A2 (sPLA(2)-IIA), lipoprotein (a) [Lp(a)], soluble intercellular adhesion molecule-1 (sICAM-1) and soluble platelet endothelial CAM-1 (sPECAM-1), as well as ICAM-1 (K469E) and PECAM-1 (Leu125Val) gene polymorphisms, in patients with unstable angina pectoris (UAP) and stable AP (SAP). We enrolled 75 patients with SAP, 72 with UAP and 80 controls without angina. Blood samples were obtained before angiography. The concentrations of sPLA(2)-IIA, sICAM-1 and sPECAM-1 were higher for UAP patients than for SAP patients and controls, and the level of Lp(a) was higher for UAP patients than for controls. Lp(a) and sPLA(2)-IIA levels were significantly correlated, and high plasma Lp(a) level (> or =300 mg/L) was an independent risk factor for angina. Lp(a) may play an important role in the development of angina. Further research should investigate the role of sPLA(2)-IIA, sICAM-1 and sPECAM-1 in UAP.
    No preview · Article · Sep 2008 · Clinical biochemistry

Publication Stats

10 Citations
4.21 Total Impact Points


  • 2009
    • Beijing Medical University
      • Department of Cardiology
      Peping, Beijing, China
  • 2008
    • Peking University
      Peping, Beijing, China